Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00513513
Status:
TERMINATED
Last Update Posted:
2010-04-26
First Post:
2007-08-06
Brief Title:
TMC114-C227 A Study to Evaluate the Effectiveness and Safety of TMC114 Darunavir With a Low Dose of Ritonavir as Monotherapy no Other Anti-HIV Drugs Will be Given in Patients Who Have Never Been Treated With Antiretrovirals Anti-HIV Drugs Previously
Sponsor:
Tibotec Pharmaceuticals Ireland
Organization:
Tibotec Pharmaceuticals Ireland
Organization Data
Organization:
Tibotec Pharmaceuticals Ireland
Class:
INDUSTRY
Study ID:
CR010612
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tibotec Pharmaceuticals Ireland
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None